Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.44 --0 (-0%)
Previous Close $2.44    52 Week High $4.76 
Open $2.44    52 Week Low $1.46 
Day High $2.44    P/E N/A 
Day Low $2.44    EPS $-1.91 
Volume 5,543